Additionally, to investigate the involvement of ASGPR in the cholesterol-lowering effect of Lac-β-CyD, we examined Filipin III fluorescence after Lac-β-CyD or HP-β-CyD treatment in the presence or absence of AF (Supplementary Figure S1b, Figure 6b). The gene discussed is ASGR1; the disease is atrial fibrillation.